News & Analysis as of

Capital Structure Particulars in the Lifecycle of a Pre-Sales Revenue Biotechnology Venture Destined for IPO Success

The public securities markets and the underwriters that lead biotech companies into them dictate a common capital structure suitable for IPOs, which structure almost always deviates starkly from the capital structure of the...more

Life Sciences Financing Survey - First Half, 2013

In This Issue: - Summary - Analysis of Industry Data - Detailed Fenwick & West Results: Valuation - Detailed Fenwick & West Results: Financing Terms ...more

Funding for New Biobased Chemical Plants May Be Found Overseas, ACORE Official Says

Originally published in the Daily Environment Report on November 15, 2013. PHILADELPHIA–Finding funding to build new facilities to produce biobased chemicals and biofuels is challenging in the current economic...more

3 Results
|
View per page
Page: of 1